# Sleeping Bruxism Treatment Market

> 由于睡眠障碍患病率上升、对磨牙症相关并发症的认识不断提高，以及口腔矫治器疗法、诊断技术和个性化治疗方法的进步，预计到 2035 年，全球睡眠磨牙症治疗市场将达到 12.3043 亿美元，复合年增长率为 6.44%。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.44%
- **2024:** $ 616.69 Million
- **2025:** $ 663.47 Million
- **2035:** $ 1,230.43 Million
- **Key Players:** Johnson & Johnson (US), Procter & Gamble (US), GlaxoSmithKline (GB), Colgate-Palmolive (US), Bausch Health Companies (CA), Dentsply Sirona (US), Haleon (GB), Sunstar (JP), Oral-B (US)

**Report ID:** MRFR/HC/3979-CR · **Pages:** 130 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422

---

## Market Summary

As per MRFR analysis, the Sleeping Bruxism Treatment Market was estimated at 616.69 USD Million in 2024. The Sleeping Bruxism Treatment industry is projected to grow from 663.47 USD Million in 2025 to 1230.43 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.44% during the forecast period 2025 - 2035.

## Market Drivers

### Market Growth Projections

全球睡眠磨牙症治疗市场行业预计在未来几年将经历大幅增长。预计 2024 年该行业的市场价值将达到 5 亿美元，预计到 2035 年将大幅扩张，达到 1.23 亿美元。2025 年至 2035 年复合年增长率为 8.54%，为这一增长提供了支撑。
 
促成这种扩张的因素包括人们对磨牙症的认识不断提高、治疗技术的进步以及牙科护理支出的增加。市场轨迹表明，在消费者需求和治疗方法创新的推动下，它将继续发展。

### Rising Dental Care Expenditure

全球牙科保健支出的增加是全球睡眠磨牙症治疗市场行业的重要驱动力。随着人们优先考虑口腔健康并投资于预防性护理，对磨牙症治疗的需求可能会增加。根据最近的数据，牙科支出预计将增长，反映出注重健康的消费者行为的更广泛趋势。
 
支出的增加可能会导致牙科器具和磨牙症疗法的采用率提高，从而促进市场的预期增长。预计到 2024 年，市场规模将达到 5 亿美元，并且随着意识和支出的持续上升，预计将进一步扩大。

### Increasing Awareness of Bruxism

人们对磨牙症作为一种普遍的牙齿疾病的认识不断提高，这是全球睡眠磨牙症治疗市场行业的关键驱动力。随着越来越多的人认识到未经治疗的磨牙症的症状和潜在后果，对有效治疗的需求可能会增加。
 
牙科协会和医疗保健提供者开展的教育活动有助于提高这种意识，预计到 2024 年市场价值将达到 5 亿美元。这种意识的提高可能会鼓励患者寻求专业帮助，从而扩大各种治疗方案的市场，包括牙科防护和行为疗法。

### Integration of Behavioral Therapies

将行为疗法纳入磨牙症治疗计划正在成为全球睡眠磨牙症治疗市场行业的关键驱动力。认知行为疗法和压力管理策略等技术因其在减少磨牙症症状方面的有效性而得到认可。
 
这种整体方法不仅解决了磨牙症的身体方面问题，还解决了其心理触发因素，吸引了更广泛的患者群体。随着医疗保健提供者越来越多地采用这些疗法，市场可能会出现增长，预计到 2035 年，在磨牙症综合管理的推动下，市场价值将达到 12.3 亿美元。

### Growing Incidence of Stress and Anxiety

全球压力和焦虑症的患病率日益增加，导致磨牙症病例增加，从而影响了全球睡眠磨牙症治疗市场行业。压力是磨牙症的已知诱因，[心理健康](https://www.marketresearchfuture.com/reports/mental-health-market-12354)意识的提高，更多的人可能会寻求相关症状的治疗。
 
这种相关性表明，随着压力水平的上升，对磨牙症治疗的需求也会增加。因此，由于需要针对压力相关的磨牙症采取有效的管理策略，该市场有望实现增长，预计到 2035 年潜在市场价值将达到 12.3 亿美元。

### Technological Advancements in Treatment Options

牙科护理的技术创新正在显着影响全球睡眠磨牙症治疗市场行业。先进牙科器具的引入，例如定制的夜间防护装置和生物反馈装置，提高了治疗效果和患者舒适度。这些创新不仅改善了患者的治疗效果，还吸引了更多的人寻求治疗。
 
随着市场的发展，数字健康解决方案的集成（例如用于监测磨牙症的移动应用程序）预计将进一步推动增长。这一趋势与预计到 2035 年市场规模将扩大至 12.3 亿美元相一致，反映出 2025 年至 2035 年复合年增长率为 8.54%。

## Future Outlook

预计睡眠磨牙症治疗市场将在2025年至2035年间以6.44%的年均增长率增长，推动因素包括意识的提高和治疗选项的进步。

到2035年，市场预计将实现显著增长，反映出治疗方法的演变和消费者意识的提高。

## Segment Insights

### 按治疗类型：行为疗法（最大）与牙科夹板（增长最快）

在睡眠磨牙症治疗市场中，细分市场价值表现出独特的市场份额分布。行为疗法占据最大份额，因为从业者强调心理方法来减轻磨牙症。这是补充[牙科夹板](https://www.marketresearchfuture.com/reports/dental-splints-market-66476)，因其直接的保护作用而越来越受欢迎。与此同时，药物、物理治疗和压力管理所占比例较小但也很重要，反映了它们在综合治疗计划中的支持作用。该细分市场的增长趋势主要是由于人们越来越意识到磨牙症对牙齿健康和福祉的影响。行为疗法继续占据主导地位，因为它通过认知调整解决根本原因。然而，牙科夹板正在迅速兴起，因为它们提供直接的机械支撑，特别吸引那些寻求快速缓解的人。这种并置表明了一种多样化的治疗方法，可以满足不同患者的喜好和需求。

行为疗法（主导）与牙科夹板（新兴）

行为疗法是睡眠磨牙症治疗市场的主导力量，因为它专注于解决磨牙症的心理和情境触发因素。这种治疗形式涉及认知行为策略，旨在改变导致磨牙的习惯。其综合性凸显了其在有效管理症状方面的长期价值。相反，牙夹板作为一种新兴的治疗选择越来越受欢迎，为患有急性磨牙症的人提供了更直接的物理解决方案。当患者通过治疗或其他方法解决潜在问题时，这些矫治器可以保护牙齿免受损伤。随着越来越多的用户意识到牙科夹板的有效性，其受欢迎程度预计会上升，从而在这两种方法之间产生动态相互作用。

### 按年龄组：儿童（最大）与成人（增长最快）

在睡眠磨牙症治疗市场中，不同年龄组的市场份额分布表明，儿童占有很大一部分，这很大程度上是由于该人群中磨牙症的患病率很高。这通常归因于压力、牙齿不齐或儿童时期出现的发育问题等因素，使它们成为治疗举措的焦点。与此同时，由于现代生活方式中压力和焦虑水平不断增加，成年人口越来越多地面临磨牙症，导致对定制治疗方案的需求不断增长。增长趋势表明，虽然儿童仍然是最大的群体，但成人正成为增长最快的群体。生活方式的改变，包括与就业相关的压力源和焦虑的增加，引发了成年人磨牙症病例的激增。此外，人们对与未经治疗的磨牙症相关的牙科并发症的认识不断提高，正在为针对该年龄段的创新治疗解决方案培育更大的市场，包括夜间监护和压力管理技术等疗法。

儿童（主导）与成人（新兴）

在睡眠磨牙症治疗市场中，儿童占主导地位，因为他们因牙齿错位和压力等多种因素而更容易患上磨牙症。针对这一人群的治疗通常侧重于预防措施和行为疗法，专门针对年轻患者。相反，成年人是一个新兴群体，因生活方式的改变而导致磨牙症患病率不断上升。该群体更加重视高效且有效的治疗方法，从而导致对可定制夜间防护或牙科处方等先进产品的需求增加。随着人们对睡眠障碍的认识不断提高，成年人可能会寻求解决方案，这使他们成为不断发展的市场中的重要参与者。

### 按严重程度划分：中等（最大）与严重（增长最快）

在睡眠磨牙症治疗市场中，细分分布显示，中等严重程度的病例所占份额最大，因为它们是患者中最常被诊断出来的。由于大量个体出现中度症状，此类治疗的需求很大，确保为患者提供多种治疗选择。重症病例虽然较少发生，但因其对患者生活质量的显着影响而迅速引起市场关注，需要先进的治疗方式和管理实践的创新。

严重程度：中度（主导）与重度（新兴）

中度严重程度的细分市场是睡眠磨牙症治疗市场的主导力量，这主要是由于其普遍存在。此类患者经常会经历明显的磨痛和不适，从而提高认识并采取积极主动的治疗方法。他们接受一系列干预措施，从简单的生活方式改变到定制的夜班守卫。相反，重症部分被归类为新兴疾病，其特点是迫切需要强化管理策略，包括药物和治疗干预措施。随着人们对严重磨牙症严重影响的认识不断增强，该群体的治疗方案正在迅速发展，使其成为新市场进入者和现有主要参与者的焦点。

### 按诊断方法：临床检查（最大）与肌电图检查（增长最快）

睡眠磨牙症治疗市场的诊断方法分布明显，其中临床检查占据最大的市场份额。这种传统方法因其成本效益高且易于在临床环境中实施而被广泛使用。患者病史也发挥着至关重要的作用，因为它为患者的行为模式提供了宝贵的见解。肌电图和成像技术正在成为重要的参与者，特别是在高级诊断领域，电神经生理学评估因其精确度和准确性而受到欢迎。

临床检查（主导）与肌电图（新兴）

临床检查仍然是睡眠磨牙症治疗市场的主导方法，主要是因为其在常规牙科评估中的可及性和直接应用。它允许从业者通过视觉和触觉方法识别磨牙症，包括检查牙齿磨损的迹象。另一方面，肌电图是一种新兴技术，因其能够提供与磨牙症相关的肌肉活动的定量数据而迅速受到关注。虽然它需要专门的设备，但其精度和诊断能力使其成为专家的首选，从而逐渐将其定位为该领域的重要诊断工具。

### 按治疗持续时间：短期（最大）与长期（增长最快）

睡眠磨牙症治疗市场中治疗持续时间部分的市场份额分布显示出对短期治疗的明显偏好。短期解决方案通常包括牙齿防护或行为疗法，由于其立竿见影和可及性而在市场上占据主导地位。相比之下，中期和长期治疗虽然重要，但在整个市场中所占份额较小。认知行为疗法等长期治疗方法在寻求更可持续解决方案的消费者中越来越受欢迎。

短期（主导）与长期（新兴）

睡眠磨牙症的短期治疗方法，例如咬合夹板和行为矫正，目前是市场上的主导力量，吸引了寻求快速缓解症状的消费者。这些解决方案经常受到牙科专业人士的推荐，因为它们在即时症状管理方面非常有效，并且得到了强调快速见效的广泛营销策略的支持。相反，长期治疗代表了一种新兴趋势，因为人们对磨牙症根本原因的认识不断提高，促使患者采取综合治疗方法。这些长期策略侧重于解决根本原因，例如压力管理和睡眠优化，从而将自己定位为持久缓解的可持续替代方案。

## Regional Market Share Analysis

### North America : Market Leader in Treatment

North America is poised to maintain its leadership in the Sleeping Bruxism Treatment Market, holding a significant market share of $310.0 million as of 2024. The region's growth is driven by increasing awareness of sleep disorders, advancements in treatment options, and supportive healthcare policies. Regulatory bodies are actively promoting research and development, which further fuels market expansion. The rising prevalence of stress-related conditions also contributes to the growing demand for effective treatments. The competitive landscape in North America is robust, featuring key players such as GlaxoSmithKline, Pfizer, and Johnson & Johnson. These companies are investing heavily in innovative therapies and clinical trials to enhance their product offerings. The US sleeping bruxism treatment market stands out as the leading ecosystem, supported by a well-established healthcare infrastructure and a high rate of healthcare expenditure. This environment fosters collaboration between pharmaceutical companies and research institutions, ensuring a steady pipeline of new treatments.

### Europe : Emerging Market Dynamics

Europe is witnessing a notable increase in the Sleeping Bruxism Treatment Market, with a market size of €180.0 million projected for December 2025. Factors such as rising awareness of oral health, increased stress levels, and a growing aging population are driving demand for effective treatment solutions. Regulatory frameworks in the region are becoming more supportive, encouraging innovation and ensuring that products meet high safety standards, which is crucial for consumer trust. Leading countries in Europe, such as Germany, France, and the UK, are at the forefront of this market. The competitive landscape includes major players like GlaxoSmithKline and Haleon, who are actively expanding their product lines. The presence of advanced healthcare systems and a focus on preventive care further enhance market opportunities, positioning Europe as a key player in the global landscape.

### Asia-Pacific : Rapid Growth Potential

The Asia-Pacific region is emerging as a significant player in the Sleeping Bruxism Treatment Market, with a market size of $100.0 million anticipated by December 2025. The growth is fueled by rising disposable incomes, increasing awareness of dental health, and a surge in stress-related disorders. Regulatory bodies are beginning to implement guidelines that promote safe and effective treatment options, which is essential for market growth and consumer confidence. Countries like Japan, Australia, and China are leading the charge in this market. The competitive landscape is characterized by the presence of key players such as Sunstar and Dentsply Sirona, who are focusing on product innovation and strategic partnerships. The growing emphasis on preventive healthcare and the expansion of dental services in urban areas are further driving market expansion in this region.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually developing its Sleeping Bruxism Treatment Market, with a market size of $36.69 million projected for December 2025. The growth is primarily driven by increasing awareness of dental health issues and a rising prevalence of sleep disorders. Regulatory frameworks are evolving, which is essential for ensuring the safety and efficacy of treatment options available in the market, thus fostering consumer trust and market growth. Leading countries in this region include South Africa and the UAE, where there is a growing focus on improving healthcare infrastructure. The competitive landscape is still emerging, with opportunities for both local and international players to establish a foothold. Companies are beginning to invest in awareness campaigns and product development, aiming to cater to the unique needs of consumers in this diverse region.

## Competitive Benchmarking

睡眠磨牙症治疗市场目前的特点是竞争格局既动态又多方面。主要增长动力包括口腔健康意识的提高、睡眠障碍发病率的上升以及对有效治疗方案的需求不断增长。强生公司（美国）、宝洁公司（美国）和葛兰素史克公司（英国）等主要参与者都在战略上做好了利用这些趋势的准备。强生（美国）专注于牙科护理产品的创新，而宝洁（美国）则强调消费者教育和产品可及性。葛兰素史克（GB）正在投资研发以增强其产品供应，从而塑造越来越依赖创新和消费者参与的竞争环境。在业务策略方面，公司正在本地化制造以降低成本并优化供应链，这在适度分散的市场中尤其重要。这些关键参与者的集体影响力是巨大的，因为他们不仅推动产品开发，还制定了小公司必须遵守的行业标准。这种竞争结构允许提供多种治疗选择，满足不同消费者的需求和偏好。
11 月，宝洁公司（美国）宣布推出专为磨牙症患者设计的新系列夜间防护服，采用先进材料，提高舒适度和有效性。这一战略举措可能会通过满足消费者对更有效和用户友好的解决方案的需求来加强他们的市场地位。该产品的推出反映了治疗方案创新的更广泛趋势，这对于保持该领域的竞争优势至关重要。
10 月，葛兰素史克（英国）透露与一家领先的技术公司合作开发一款人工智能驱动的应用程序，旨在监测磨牙症症状。这一举措不仅展示了葛兰素史克将技术融入医疗保健的承诺，而且使该公司处于数字健康解决方案的前沿。实时数据收集和个性化治疗计划的潜力可以显着提高患者的治疗效果和参与度。
九月，强生（美国）收购了一家专门从事睡眠健康技术的初创公司，扩大了其产品线。此次收购标志着对睡眠相关疾病采取更全面的方法的战略转变，表明强生公司（美国）热衷于在传统领域之外实现产品多元化[牙科产品](https://www.marketresearchfuture.com/reports/dental-products-market-21469)。这些举措可以通过提供全面的解决方案来解决磨牙症的根本原因，从而增强他们的竞争优势。
截至 12 月，睡眠磨牙症治疗市场当前的竞争趋势在很大程度上受到数字化、可持续性和人工智能技术集成的影响。战略联盟正在日益塑造格局，使公司能够汇集资源和专业知识，更有效地进行创新。展望未来，差异化竞争似乎将从传统的基于价格的竞争演变为注重创新、技术进步和供应链可靠性。这种转变可能会重新定义市场动态，迫使公司将长期价值创造置于短期收益之上。

## Recent News & Developments

- In January 2021, Henry Schein, Inc. acquired majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies. With this transaction, Henry Schein Medical, the US medical division of Henry Schein, Inc., enters an established and growing multibillion-dollar market for home medical equipment and supplies.
- In June 2020, Carestream Dental entered into a partnership with Unified Smiles, a management consulting firm based in the US. Under the partnership, Carestream Dental will provide support, guidance, and education to independent practices.

## Report Scope

| MARKET SIZE 2024 | 616.69(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 663.47(USD Million) |
| MARKET SIZE 2035 | 1230.43(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.44% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Johnson & Johnson (US), Procter & Gamble (US), GlaxoSmithKline (GB), Colgate-Palmolive (US), Bausch Health Companies (CA), Dentsply Sirona (US), Haleon (GB), Sunstar (JP), Oral-B (US) |
| Segments Covered | Treatment Type, Age Group, Severity Level, Diagnosis Method, Treatment Duration |
| Key Market Opportunities | Integration of digital therapeutics and personalized treatment plans in the Sleeping Bruxism Treatment Market. |
| Key Market Dynamics | Rising consumer awareness and demand for effective treatments drive innovation in the sleeping bruxism treatment market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Sleeping Bruxism Treatment Market?**
A: The market valuation was 616.69 USD Million in 2024.

**Q: What is the projected market size for the Sleeping Bruxism Treatment Market by 2035?**
A: The projected valuation for 2035 is 1230.43 USD Million.

**Q: What is the expected CAGR for the Sleeping Bruxism Treatment Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 6.44%.

**Q: Which treatment types are leading in the Sleeping Bruxism Treatment Market?**
A: Dental Splints and Medications are among the leading treatment types, with valuations of 184.99 to 370.43 USD Million and 123.34 to 246.09 USD Million, respectively.

**Q: How does the market segment by age group?**
A: The market segments by age group, with Adults representing 400.0 to 800.0 USD Million, followed by Adolescents at 70.0 to 150.0 USD Million.

**Q: What are the key players in the Sleeping Bruxism Treatment Market?**
A: Key players include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Merck & Co.

**Q: What is the market performance based on severity levels of bruxism?**
A: The market shows notable performance in the Moderate and Severe categories, each valued between 184.99 and 369.98 USD Million.

**Q: What diagnostic methods are utilized in the Sleeping Bruxism Treatment Market?**
A: Dental Imaging leads the diagnostic methods with a valuation of 246.69 to 390.43 USD Million.

**Q: How does behavioral therapy contribute to the market?**
A: Behavioral Therapy contributes with a valuation range of 61.67 to 123.04 USD Million.

**Q: What trends are anticipated in the Sleeping Bruxism Treatment Market by 2035?**
A: Trends suggest a continued growth trajectory, with increasing awareness and treatment options likely driving market expansion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422*